Evidence map›Paper›PMID 37706154›Full record

ArticleFrontiers in neuroscience2023

Evaluation of deep learning models for quality control of MR spectra.

Sana Vaziri, Huawei Liu, Emily Xie, Hélène Ratiney, Michaël Sdika, Janine M Lupo, Duan Xu, Yan Li

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sana VaziriDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States.
Huawei LiuDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States.
Emily XieDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States.
Hélène RatineyUniv Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, Lyon, France.
Michaël SdikaUniv Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, CREATIS UMR 5220, Lyon, France.
Janine M LupoDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States.
Duan XuDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States.
Yan LiDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States.

Funding

Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade AstrocytomaR01CA273028 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORDON, JEREMY WILLIAM, LI, YAN · 2022 to 2025
$3.3M
Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with GliomaR01CA262630 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Susan M Chang, Albert Chen · 2022 to 2026
$3.3M
Simultaneous multi-slice GABA-edited MRSI in the developing brainR21HD092660 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LI, YAN · 2017 to 2018
$436k
NCI NIH HHS R01 CA262630NCI NIH HHS R01 CA273028NICHD NIH HHS R21 HD092660
6 · The paper itself

Abstract

Purpose: While 3D MR spectroscopic imaging (MRSI) provides valuable spatial metabolic information, one of the hurdles for clinical translation is its interpretation, with voxel-wise quality control (QC) as an essential and the most time-consuming step. This work evaluates the accuracy of machine learning (ML) models for automated QC filtering of individual spectra from 3D healthy control and patient datasets. Methods: A total of 53 3D MRSI datasets from prior studies (30 neurological diseases, 13 brain tumors, and 10 healthy controls) were included in the study. Three ML models were evaluated: a random forest classifier (RF), a convolutional neural network (CNN), and an inception CNN (ICNN) along with two hybrid models: CNN + RF, ICNN + RF. QC labels used for training were determined manually through consensus of two MRSI experts. Normalized and cropped real-valued spectra was used as input. A cross-validation approach was used to separate datasets into training/validation/testing sets of aggregated voxels. Results: All models achieved a minimum AUC of 0.964 and accuracy of 0.910. In datasets from neurological disease and controls, the CNN model produced the highest AUC (0.982), while the RF model achieved the highest AUC in patients with brain tumors (0.976). Within tumor lesions, which typically exhibit abnormal metabolism, the CNN AUC was 0.973 while that of the RF was 0.969. Data quality inference times were on the order of seconds for an entire 3D dataset, offering drastic time reduction compared to manual labeling. Conclusion: ML methods accurately and rapidly performed automated QC. Results in tumors highlights the applicability to a variety of metabolic conditions.

Indexed as

convolutional neural networkmachine learningMR spectroscopyquality controlrandom forest

Identifiers

PMID37706154
PMCPMC10495580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.